Loading clinical trials...
Loading clinical trials...
The aim of this study will evaluate the effectiveness of 0.12% chlorhexidine solution as an anti-inflammatory agent and reducing the presence of biofilm in young adults.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Universidade Federal Fluminense
NCT06141798 · Age Problem, Dialysis; Complications, and more
NCT07304024 · Central Auditory Processing Disorder, Hearing Impaired (Partially), and more
NCT05593692 · Emergencies, Gender, and more
NCT06686186 · Cognitive Impairment, Dementia, and more
NCT06472674 · Age Problem, Disability, and more
Universidade Federal Fluminense
Nova Friburgo, Rio de Janeiro
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions